Islet inflammation: a unifying target for diabetes treatment?
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
In the last decade, islet inflammation has emerged as a contributor to the loss of functional β cell mass in both type 1 (T1D) and type 2 diabetes (T2D). Evidence supports that over-nutrition and insulin resistance result in the production of proinflammatory mediators by β cells. In addition to compromising β cell function and survival, cytokines may recruit macrophages into islets, thus augmenting inflammation. Limited, but intriguing, data implies a role of adaptive immune response in islet dysfunction in T2D. Clinical trials validated anti-inflammatory therapies in T2D, while immune therapy for T1D remains challenging. Further research is required to improve our understanding of islet inflammatory pathways, and to identify more effective therapeutic targets for T1D and T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 4×
“Gut microbes manifest unique changes in obesity that are associated with the increase in circulatory lipopolysaccharide (LPS) [34].”
BackgroundInfluentialType 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Adipose tissue remodeling and obesity
Sun, K., Kusminski, C. M., & Scherer, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45887 · Cited by 1,941
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Mechanisms of Pancreatic β-Cell Death in Type 1 and Type 2 Diabetes
Cnop, M., Welsh, N., Jonas, J.-C., Jörns, A., Lenzen, S., & Eizirik, D. L. (2005) · Diabetes · doi:10.2337/diabetes.54.suppl_2.s97 · Cited by 1,491 · cited 1×
“However, one needs to note that there remain differences between the two forms of diabetes including typical clinical presentation, rate of β cell destruction, profiles of autoantibodies, and histology of islets [18, 93, 94].”
BackgroundMasters, S. L., Dunne, A., Subramanian, S. L., Hull, R. L., Tannahill, G. M., Sharp, F. A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., et al. (2010) · Nature Immunology · doi:10.1038/ni.1935 · Cited by 1,330 · cited 2×
“Recently, studies showed that IAPP aggregates may actively contribute to islet dysfunction in T2D by provoking an inflammatory response [31, 33].”
BackgroundReceptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
Holland, W. L., Miller, R. A., Wang, Z. V., Sun, K., Barth, B. M., Bui, H. H., Davis, K. E., Bikman, B. T., Halberg, N., Rutkowski, J. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2277 · Cited by 892 · cited 1×
“In vivo mouse studies indicate that many of the adiponectin actions may be mediated via generation of sphingosine 1-phosphate [83].”
BackgroundRidker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
Tersey, S. A., Nishiki, Y., Templin, A. T., Cabrera, S. M., Stull, N. D., Colvin, S. C., Evans-Molina, C., Rickus, J. L., Maier, B., & Mirmira, R. G. (2012) · Diabetes · doi:10.2337/db11-1293 · Cited by 353
Oxidative stress and beta-cell dysfunction
Drews, G., Krippeit-Drews, P., & Düfer, M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0862-9 · Cited by 315 · cited 1×
“The elevated glucose and FFA levels, commonly seen in T2D, are known to cause oxidative stress [17, 21].”
BackgroundMarselli, L., Thorne, J., Dahiya, S., Sgroi, D. C., Sharma, A., Bonner-Weir, S., Marchetti, P., & Weir, G. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011499 · Cited by 313 · cited 1×
“Microarray analysis of human islets obtained by laser microdissection showed differential regulation of oxidative stress genes in T2D donors, compared with controls, implicating oxidative stress in islet dysfunction [22].”
BackgroundBrookheart, R. T., Michel, C. I., & Schaffer, J. E. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.011 · Cited by 279 · cited 1×
“The exposure of cells to pure PA does not necessarily mirror the hyperlipidemia generated in vivo from the mixture of FFA including unsaturated fatty acids such as oleic acid (OA) [20].”
BackgroundWijesekara, N., Krishnamurthy, M., Bhattacharjee, A., Suhail, A., Sweeney, G., & Wheeler, M. B. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085084 · Cited by 229 · cited 1×
“Adiponectin receptors are expressed in primary and clonal β cells and signal through AMPK, PPARγ, PPARα, and p38MAPK [84].”
BackgroundDobrian, A. D., Ma, Q., Lindsay, J. W., Leone, K. A., Ma, K., Coben, J., Galkina, E. V., & Nadler, J. L. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00463.2010 · Cited by 166 · cited 1×
“Although it is not clear if obesity is associated with increased levels of DPPIV, inhibition of the latter by sitagliptin in a rodent model of obesity and insulin resistance reduced inflammatory cytokine production both in islets and in AT, and improved glucose-stimulated insulin secretion (GSIS) in islets in vitro [1…”
BackgroundSelf-citationCaton, P. W., Kieswich, J., Yaqoob, M. M., Holness, M. J., & Sugden, M. C. (2011) · Diabetologia · doi:10.1007/s00125-011-2288-0 · Cited by 140 · cited 1×
“Nicotinamide mononucleotide (NMN), a metabolite that augments sirtuin action, rescues islets from reduced insulin secretion after IL-1 β and TNFα exposure [77].”
BackgroundMetabolic stress, IAPP and islet amyloid
Montane, J., Klimek‐Abercrombie, A., Potter, K. J., Westwell‐Roper, C., & Bruce Verchere, C. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01657.x · Cited by 98
Recent Lessons Learned From Prevention and Recent-Onset Type 1 Diabetes Immunotherapy Trials
Staeva, T. P., Chatenoud, L., Insel, R., & Atkinson, M. A. (2013) · Diabetes · doi:10.2337/db12-0562 · Cited by 91
Dula, S. B., Jecmenica, M., Wu, R., Jahanshahi, P., Verrilli, G. M., Carter, J. D., Brayman, K. L., & Nunemaker, C. S. (2010) · Cell Calcium · doi:10.1016/j.ceca.2010.07.007 · Cited by 83
Identification of Autoantibody-Negative Autoimmune Type 2 Diabetic Patients
Brooks-Worrell, B. M., Reichow, J. L., Goel, A., Ismail, H., & Palmer, J. P. (2011) · Diabetes Care · doi:10.2337/dc10-0579 · Cited by 83 · cited 1×
“However, peripheral blood T cells from 42% of clinically defined T2D patients react against islet extracts, despite of the lack of islet antibodies in these patients, suggesting that adaptive immunity may be involved at a significant frequency in clinically defined T2D (Box 3) [63].”
Background
Cited by
Ertunc, M. E., & Hotamisligil, G. S. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066514 · Cited by 488
Inflammation and the Metabolic Syndrome: The Tissue-Specific Functions of NF-κB
Catrysse, L., & van Loo, G. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.01.006 · Cited by 329
Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction
Khodabandehloo, H., Gorgani-Firuzjaee, S., Panahi, G., & Meshkani, R. (2016) · Translational Research · doi:10.1016/j.trsl.2015.08.011 · Cited by 295
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
Brennan, E., Kantharidis, P., Cooper, M. E., & Godson, C. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00454-y · Cited by 262
Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes
Hasnain, S. Z., Prins, J. B., & McGuckin, M. A. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0232 · Cited by 253
Metadata
- Authors
- Imai, Y., Dobrian, A. D., Morris, M. A., & Nadler, J. L.
- Venue
- Trends in Endocrinology & Metabolism
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 24
- Issue
- 7
- Pages
- 351-360
- ISSN
- 1043-2760 (ISSN-L)
- OpenAlex
- W2025202152
- Cited by
- 119
- References
- 19
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.